White House Says FDA Not Pressured to Approve COVID-19 Vaccine Before November Vote
WASHINGTON, September 3- White House spokesperson Kayleigh McEnany told reporters on Thursday that the Food and Drug Administration is not being pressured by anybody to approve a novel coronavirus vaccine before the upcoming November 3 presidential elections as has been alleged by the mainstream media. “This is again a bizarre theory spun up by CNN among…
WASHINGTON, September 3 (Sputnik) – White House spokesperson Kayleigh McEnany told reporters on Thursday that the Food and Drug Administration (FDA) is not being pressured by anybody to approve a novel coronavirus vaccine before the upcoming November 3 presidential elections as has been alleged by the mainstream media.
“No one is pressuring the FDA to do anything,” McEnany said. “This is again a bizarre theory spun up by CNN among others.”
McEnany said US President Donald Trump wants to break through the regulatory barriers so that a vaccine can be produced and provided to the American people as quickly as possible.
“But he will not in any way sacrifice safety and making sure that is 100 percent airtight for the American people to receive it,” McEnany said. “So, the priority here is saving lives, safety, and there will be a safe and effective vaccine in the works.”
On Sunday, FDA head Stephen Hahn said in an interview the agency is ready to authorize a coronavirus vaccine before the end of phase 3 clinical trials if such a move proves to bring more benefits than risks.
Hahn also said FDA’s authorization for the emergency use of a potential vaccine did not equal full approval. FDA’s decisions would be based on science and medicine and not on politics or the upcoming election, he added.
ANA NEWS WIRE Disclaimer:
The African News Agency (ANA) is a news wire service and therefore subscribes to the highest standards of journalism as it relates to accuracy, fairness and impartiality.
ANA strives to provide accurate, well sourced and reliable information across Text, Images and Video. Where errors do appear, ANA will seek to correct these timeously and transparently.
The ANA platform also contains news and information from third party sources. ANA has sought to procure reliable content from trusted news sources but cannot be held responsible for the accuracy and opinions provided by such sources on the ANA platform or linked sites.
The content provided for on the ANA News Wire platform, both through the ANA news operation and via its third party sources, are for the sole use of authorised subscribers and partners. Unauthorised access to and usage of ANA content will be subject to legal steps. ANA reserves its rights in this regard.
ANA makes every effort to ensure that the website is up and running smoothly at all times, however ANA does not take responsibility for, and will not be held liable for times when the website is temporarily unavailable due to technical issues that are beyond our control.